Dr Catherine Hansen, PHD, MP | |
740 Keyser Ave Ste B, Natchitoches, LA 71457-6037 | |
(318) 357-3311 | |
Not Available |
Full Name | Dr Catherine Hansen |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 740 Keyser Ave Ste B, Natchitoches, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538281381 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr Catherine Hansen, PHD, MP 740 Keyser Ave, Natchitoches Va Comm. Based Outpatient Clinic, Ste. B, Natchitoches, LA 71457-6037 Ph: (318) 357-3311 | Dr Catherine Hansen, PHD, MP 740 Keyser Ave Ste B, Natchitoches, LA 71457-6037 Ph: (318) 357-3311 |
News Archive
Merck KGaA, Darmstadt, Germany, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials today announced that the U.S. Food and Drug Administration has granted Fast Track designation for the development of evofosfamide (previously known as TH-302), administered in combination with gemcitabine, for the treatment of previously untreated patients with metastatic or locally advanced unresectable pancreatic cancer.
The cancellation last fall of a Merck HIV/AIDS vaccine trial was "branded as a 'catastrophe' by one scientist and as setting the race for a cure 'back to square one' by others," a Washington Post editorial says, adding, "The hyperbole is understandable, but some perspective is in order."
Although gluten-free foods are trendy among the health-conscious, they are necessary for those with celiac disease. But gluten, the primary trigger for health problems in these patients, may not be the only culprit. Scientists are reporting in ACS' Journal of Proteome Research that people with the disease also have reactions to non-gluten wheat proteins. The results could help scientists better understand how the disease works and could have implications for how to treat it.
Synthetic Biologics, Inc.), a clinical stage company focused on developing therapeutics to protect the gut microbiome while targeting pathogen specific diseases, announced positive topline results from the first Phase 2a study of SYN-004, the Company's candidate designed to protect the gut microbiome from the unintended effects of certain commonly used intravenous (IV) beta-lactam antibiotics for the prevention C. difficile infection (CDI) and antibiotic-associated diarrhea (AAD).
› Verified 8 days ago
Dr. Kathryn E Kelly, PSYCHOLOGIST Psychologist Medicare: Not Enrolled in Medicare Practice Location: 311 Church St, Natchitoches, LA 71457 Phone: 318-581-0128 | |
Dr. Carol Jannik, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 226 South Dr, Natchitoches, LA 71457 Phone: 318-354-1188 Fax: 318-354-1189 | |
Dr. Lee B Kneipp, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 311 Church St, Natchitoches, LA 71457 Phone: 318-542-9805 |